Roche Aktie

301,80 EUR -2,10 EUR -0,69 %

31.01.2025

L&S

286,00 CHF +0,80 CHF +0,28 %

31.01.2025

SWX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.236,51 Mrd. EUR

KGV21,69

WKN855167

ISINCH0012032048

SymbolRHHVF

Roche Aktien News

Sortieren:Datum Meistgelesen

23.03.20ReutersRoche CEO says broad coronavirus testing in U.S. could take weeks - CNBC

23.03.20ReutersRoche gets U.S. FDA nod for trial to test arthritis drug on coronavirus patients

23.03.20ReutersRoche CEO says broad coronavirus testing will take weeks - CNBC

19.03.20ReutersUPDATE 1-Roche CEO says coronavirus test capacity too limited to screen all

19.03.20ReutersRoche CEO says coronavirus test capacity too limited to screen all

19.03.20ReutersRoche to test Actemra in coronavirus patients as firms re-purpose drugs

13.03.20ReutersFDA works to speed coronavirus tests with Roche, New York approvals

13.03.20ReutersUPDATE 2-U.S. FDA works to speed coronavirus tests with Roche, New York approvals

13.03.20ReutersNew Roche coronavirus test wins emergency U.S. approval

13.03.20ReutersUPDATE 1-New Roche coronavirus test wins emergency U.S. approval

10.03.20ReutersRoche tells Spanish staff to work remotely as coronavirus spreads

04.03.20ReutersUPDATE 1-China approves use of Roche drug in battle against coronavirus complications

04.03.20ReutersChina approves use of Roche arthritis drug for coronavirus patients

03.03.20ReutersCORRECTED-Roche pushes to kick-start lung therapy Esbriet after big writedown

03.03.20ReutersRoche pushes to kick-start lung therapy Esbriet after big writedown

10.02.20ReutersRoche, Lilly drugs fail to halt gene-driven Alzheimer's disease

10.02.20ReutersUPDATE 2-Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease

10.02.20ReutersUPDATE 1-Roche drug fails in early-onset Alzheimer's disease study

10.02.20ReutersRoche drug fails in early-onset Alzheimer's disease study

30.01.20ReutersRoche says closed Chinese cities hinder virus diagnostics test deliveries

22.01.20ReutersRoche wins approval for cancer drug Kadcyla in fast-growing China market

14.01.20ReutersRoche aims to 'underwhelm' on SMA drug price to challenge rivals

23.12.19ReutersUPDATE 1-Roche enters $1.15 bln licensing deal for Sarepta gene therapy

23.12.19ReutersRoche enters $1.15 billion licensing deal for Sarepta gene therapy

23.12.19ReutersRoche enters $1.15 bln licensing deal for Sarepta gene therapy

17.12.19ReutersRoche to complete $4.3 billion Spark deal as regulators give all clear

17.12.19ReutersUPDATE 3-Roche to complete $4.3 bln Spark deal as regulators give all clear

17.12.19ReutersRoche has 60.4% of Spark, plans to wrap up takeover on Tuesday

16.12.19ReutersU.S. antitrust enforcers give Roche approval to buy Spark Therapeutics

16.12.19ReutersUS antitrust enforcers give Roche approval to buy Spark Therapeutics

16.12.19ReutersUPDATE 1-Roche clears UK hurdle in $4.3 bln Spark deal, U.S. review drags on

16.12.19ReutersRoche wins UK clearance for $4.3 billion Spark takeover as U.S. review continues

16.12.19ReutersRoche wins UK clearance for $4.3 bln Spark takeover as U.S. review continues

09.12.19ReutersSwiss drugmaker Roche again extends $4.3 bln Spark offer until Dec. 16

25.11.19ReutersRoche eyes quick FDA approval in SMA race with Biogen, Novartis

25.11.19ReutersUPDATE 1-Roche eyes quick FDA approval in SMA race with Biogen, Novartis

25.11.19ReutersRoche eyes quick FDA approval in SMA race with Biogen, Novartis

22.11.19ReutersUPDATE 1-Roche says Tecentriq cocktail helps liver cancer patients live longer

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.